Download - gnipst bulletin 29.4.pdf
-
7/27/2019 gnipst bulletin 29.4.pdf
1/15
1
1118-1177-4796-9849-7562-5062mail
GGGNNNIIIPPPSSSTTTBBBUUULLLLLLEEETTTIIINNN 222000111333
25th
October , 2013 Volume No.: 29 Issue No.: 0
Contents Message from GNIPS
Letter to the Editor News Update
Health awareness
Disease Outbreak Ne
Forth Coming Events
Drugs Update
Campus News
Students Section
Editors Note
Archive
Vision
TO GROW AS A CENTRE OF EXCELLENCE IN THE FIELD O
PHARMACEUTICAL AND BIOLOGICAL SCIENCE
EDITOR: Soumya BhattacharyaGURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND
TECHNOLOGY
GNIPST Photo Gallery
For your comments/contributionORFor Back-Issues,
mailto:[email protected]
https://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7mailto:[email protected]:[email protected]:[email protected]://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7 -
7/27/2019 gnipst bulletin 29.4.pdf
2/15
25-10-2013
Click here to go at the top
MESSAGE FROM GNIPSTGNIPST BULLETIN is the official publication of Guru Nanak
Institute of Pharmaceutical Science & Technology. All the members
of GNIPST are proud to publish the 29th Volume of GNIPSTBULLETIN. Over the last two years this bulletin updating readers
with different scientific, cultural or sports activities of this
prestigious institute and promoting knowledge of recent development
in Pharmaceutical and Biological Sciences. Students section is
informing readers about some curious facts of drug discovery, science,
sports and other relevant fields. We look forward to seeing your
submission and welcome comments and ideas you may have.
LETTER TO THE EDITOR.
NEWS UPDATE
World Polio Day,2013 (24thOctober, 2013)
World Polio Day was observed globally on 24th
October. World PolioDay aims to shed light on October 24th, which marks the month in
which Jonas Salk was born (28th October). Jonas was the leader of
the team that invented the first polio vaccine in 1955. Polio was once a
disease feared worldwide, striking suddenly and paralysing mainly
children for life. There are several partners in the Global Polio
Eradication Initiative, the largest private-public partnership for
health, which has reduced polio by 99%. Polio now survives onlyamong the world's poorest and most marginalized communities,
where it stalks the most vulnerable children. The Initiative's goal is to
reach every last child with polio vaccine and ensure a polio free world
for future generations.Read more
1
http://www.polioeradication.org/tabid/488/iid/327/Default.aspxhttp://www.polioeradication.org/tabid/488/iid/327/Default.aspxhttp://www.polioeradication.org/tabid/488/iid/327/Default.aspxhttp://www.polioeradication.org/tabid/488/iid/327/Default.aspx -
7/27/2019 gnipst bulletin 29.4.pdf
3/15
25-10-2013
Click here to go at the top
Experimental drug reduces brain damage in rodents
afflicted by stroke (25thOctober, 2013)
An experimental drug called 3K3A-APC appears to reduce brain
damage, eliminate brain hemorrhaging and improve motor skills in
older stroke-afflicted mice and stroke-afflicted rats with comorbid
conditions such as hypertension, according to a new study from Keck
Medicine of USC.Read more
Genetic variants associated with bronchodilatorresponsiveness (25thOctober, 2013)
A new study from Brigham and Women's Hospital (BWH) reveals
several new gene variants that are associated with how people living
with chronic obstructive pulmonary disease (COPD) respond to
inhaled bronchodilators. COPD is a progressive breathing disorder
that limits airflow in the lungs. Bronchodilators are medicines used toalleviate respiratory disorder symptoms.Read more
High-Dose Statins Reduce Gum Inflammation in
Heart Disease Patients(3 rd October, 2013)
Statins, commonly prescribed medications for lowering cholesterol,
also reduced inflammation associated with gum disease in a newstudy published in the Journal of the American College of Cardiology. The
study suggests that steps taken to reduce gum disease may also
reduce inflammation in the arteries and vice versa.Read more
2
http://www.sciencedaily.com/releases/2013/10/131025091951.htmhttp://www.sciencedaily.com/releases/2013/10/131025091951.htmhttp://www.sciencedaily.com/releases/2013/10/131025091951.htmhttp://www.sciencedaily.com/releases/2013/10/131025091951.htmhttp://www.sciencedaily.com/releases/2013/10/131025091951.htmhttp://www.sciencedaily.com/releases/2013/10/131002185652.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/10/131002185652.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/10/131002185652.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/10/131002185652.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/10/131025091951.htmhttp://www.sciencedaily.com/releases/2013/10/131025091951.htm -
7/27/2019 gnipst bulletin 29.4.pdf
4/15
25-10-2013
Click here to go at the top
Anti-Cancer drug benefits women with breast
cancer who have failed previous treatments (27thSeptember, 2013)
First results from a phase III clinical trial of the combination drug, T-
DM1, show that it significantly improves the length of time before the
disease worsens in women with advanced HER2 positive breast
cancer whose cancer has recurred or progressed despite previous
treatments, including trastuzumab and lapatinib.Read more
HEALTH AWARENESS
Polio-An overview
Polio is a highly infectious disease caused by a virus. It invades the
nervous system, and can cause total paralysis in a matter of hours. Thevirus enters the body through the mouth and multiplies in the
intestine. Initial symptoms are fever, fatigue, headache, vomiting,
stiffness in the neck and pain in the limbs. One in 200 infections leads
to irreversible paralysis (usually in the legs). Among those paralysed,
5% to 10% die when their breathing muscles become immobilized.
People most at risk
Polio mainly affects children under five years of age.
Prevention
3
http://www.sciencedaily.com/releases/2013/09/130927183142.htmhttp://www.sciencedaily.com/releases/2013/09/130927183142.htmhttp://www.sciencedaily.com/releases/2013/09/130927183142.htmhttp://www.sciencedaily.com/releases/2013/09/130927183142.htm -
7/27/2019 gnipst bulletin 29.4.pdf
5/15
25-10-2013
Click here to go at the top
There is no cure for polio, it can only be prevented. Polio vaccine,
given multiple times, can protect a child for life.
Global caseload
Polio cases have decreased by over 99% since 1988, from an estimated
350 000 cases in more than 125 endemic countries then, to 223
reported cases in 2012. In 2013, only parts of three countries in the
world remain endemic for the diseasethe smallest geographic area in
historyand case numbers of wild poliovirus type 3 are down to
lowest-ever levels.
The Global Polio Eradication Initiative
Launch
In 1988, the forty-first World Health Assembly adopted a resolution
for the worldwide eradication of polio. It marked the launch of the
Global Polio Eradication Initiative (GPEI), spearheaded by national
governments, WHO, Rotary International, the US Centers for Disease
Control and Prevention (CDC), UNICEF, and supported by key
partners including the Bill and Melinda Gates Foundation. This
followed the certification of the eradication of smallpox in 1980,
progress during the 1980s towards elimination of the poliovirus in the
Americas, and Rotary Internationals commitment to raise funds to
protect all children from the disease.
Progress
Overall, since the GPEI was launched, the number of cases has fallen
by over 99%. In 2013, only three countries in the world remain polio-
endemic: Nigeria, Pakistan and Afghanistan.
4
-
7/27/2019 gnipst bulletin 29.4.pdf
6/15
25-10-2013
Click here to go at the top
In 1994, the WHO Region of the Americas was certified polio-free,
followed by the WHO Western Pacific Region in 2000 and the WHO
European Region in June 2002. Of the three types of wild poliovirus
(type 1, type 2 and type 3), type 2 wild poliovirus transmission has
been successfully stopped (since 1999).
More than 10 million people are today walking, who would otherwise
have been paralysed. An estimated more than 1.5 million childhood
deaths have been prevented, through the systematic administration of
Vitamin A during polio immunization activities.
Opportunity and risks: an emergency approachThe strategies for polio eradication work when they are fully
implemented. This is clearly demonstrated by Indias success in
stopping polio in January 2011, in arguably the most technically-
challenging place. However, failure to implement strategic
approaches leads to ongoing transmission of the virus. Endemic
transmission is continuing in Nigeria, Pakistan and Afghanistan.
Failure to stop polio in these last remaining areas could result in asmany as 200 000 new cases every year, within 10 years, all over the
world.
Recognizing both the epidemiological opportunity and the significant
risks of potential failure, the World Health Assembly in May 2012
adopted a resolution declaring the completion of polio eradication a
programmatic emergency for global public health and called for the
development of a comprehensive polio eradication and endgame
strategy through 2018 to secure a lasting polio-free world.
Subsequently, the three remaining endemic countries launched
national polio emergency action plans, overseen in each case by the
5
-
7/27/2019 gnipst bulletin 29.4.pdf
7/15
25-10-2013
Click here to go at the top
respective head of state, and the partner agencies of the GPEI also
moved their operations to an emergency footing, working under the
auspices of the Global Emergency Action Plan 2012-2013. By the start
of 2013, the impact of the emergency approaches is being seen, with
the lowest number of reported cases in fewer districts of fewer
countries than at any previous time.
Since then, the new Polio Eradication and Endgame Strategic Plan
2013-2018 has been developed, in consultation with polio-affected
countries, stakeholders, donors, partners and national and
international advisory bodies. The new Plan was presented at a
Global Vaccine Summit in Abu Dhabi, United Arab Emirates, at theend of April 2013. It is the first plan to eradicate all types of polio
disease simultaneously both due to wild poliovirus and due to
vaccine-derived polioviruses. Global leaders and individual
philanthropists signaled their confidence in the Plan by pledging
three-quarters of the Plans projected US$5.5 billion cost over the six
years. They also called upon additional donors to commit upfront the
additional US$1.5 billion needed to secure a lasting polio-free world.Future benefits of polio eradication
Once polio is eradicated, the world can celebrate the delivery of a
major global public good that will benefit all people equally, no
matter where they live. Economic modelling has found that the
eradication of polio would save at least US$ 4050 billion over the
next 20 years, mostly in low-income countries. Most importantly,success will mean that no child will ever again suffer the terrible
effects of lifelong polio-paralysis.
6
-
7/27/2019 gnipst bulletin 29.4.pdf
8/15
25-10-2013
Click here to go at the top
(Based on WHO factsheet)
DISEASE OUTBREAK NEWS
Human infection with avian influenza A(H7N9) virus(24th October,2013)The National Health and Family Planning Commission, China
notified WHO of a new laboratory confirmed case of human infection
with avian influenza A (H7N9) virus.Read more
7
http://www.who.int/csr/don/2013_10_24a/en/index.htmlhttp://www.who.int/csr/don/2013_10_24a/en/index.htmlhttp://www.who.int/csr/don/2013_10_24a/en/index.htmlhttp://www.who.int/csr/don/2013_10_24a/en/index.html -
7/27/2019 gnipst bulletin 29.4.pdf
9/15
25-10-2013
Click here to go at the top
FORTHCOMING EVENTS
The 2nd Pharm. Tech IAPST International Conference on "New insights intodiseases and recent therapeutic approaches" from 17th to 19th January 2014 in
Kolkata, India.Read more
DRUGS UPDATES
FDA approves second brain imaging drug to help
evaluate patients for Alzheimers disease,
dementia (25th October, 2013)
The U.S. Food and Drug Administration today approved Vizamyl
(flutemetamol F 18 injection), a radioactive diagnostic drug for use
with positron emission tomography (PET) imaging of the brain inadults being evaluated for Alzheimer's disease (AD) and dementia.
Read more
CAMPUS NEWS
Students of GNIPST organized pre puja celebration programme,
Saaranya on 7th October, 2013 in college Auditorium.
GNIPST organized a garment distribution programme on 28thSeptember, 2013 at Dakshineswar Kali Temple and Adyapith,
Kolkata. On this remarkable event about hundred people have
8
http://www.iapst.com/http://www.iapst.com/http://www.iapst.com/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm372261.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm372261.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm372261.htmhttp://www.iapst.com/ -
7/27/2019 gnipst bulletin 29.4.pdf
10/15
25-10-2013
Click here to go at the top
received garments. More than hundred students and most of the
faculties participated on that day with lot of enthusiasm.
GNIPST celebrated World Heart Day (29th September) andPharmacists Day(25th September) on 25thand 26th September,
2013 in GNIPST Auditorium. A seminar on Violence against
woman and female foeticide was held on GNIPST Auditorium on
25th September organized by JABALA Action Research
Organization. On 26th September an intra-college Oral and Poster
presentation competition related to World Pharmacists day and
Heart day was held in GNIPST. Ms. Purbali Chakraborty of
B.Pharm 4th year won the first prize in Oral Presentation. Thewinner of Poster presentation was the group of Ms. Utsa Sinha,
Mr. Koushik Saha and Mr. Niladri Banerjee (B.Pharm 4th year). A
good number of students have participated in both the competition
with their valuable views.
STUDENTS SECTION
WHO CAN ANSWER FIRST????
Name of which disease was derived from Greek
word for grey?
Who first developed oral polio vaccine?Answer of Previous Issues Questions:
A) Rabies B)Louis Pasteur
9
-
7/27/2019 gnipst bulletin 29.4.pdf
11/15
25-10-2013
Click here to go at the top
Identify the personality
Solve the Puzzle
If x=3, Box=40, then Men=?
Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for StudentsSection& answers of this Section [email protected]
10
-
7/27/2019 gnipst bulletin 29.4.pdf
12/15
25-10-2013
Click here to go at the top
EDITORS NOTE
I am proud to publish the 4
th
issue of 29
th
Volume of GNIPSTBULLETIN. GNIPST BULLETIN now connected globally through
facebook account GNIPST bulletin
I want to convey my thanks to all the GNIPST members and the
readers for their valuable comments, encouragement and supports.
I am thankful to Dr. Abhijit Sengupta, Director of GNIPST for his
valuable advice and encouragement. Special thanks to Dr. Prerona
Saha andMr. Debabrata Ghosh Dastidar for their kind co-operation
and technical supports. I am thankful to Mr. Subha Bhattacharjee
for his contribution to solve the puzzle section.
An important part of the improvement of the bulletin is the
contribution of the readers. You are invited to send in your write ups,
notes, critiques or any kind of contribution for the forthcoming special
and regular issue.
ARCHIVE
Teachers daywas celebrated on 5th September, 2013 by the
students of GNIPST in GNIPST Auditorium.
Azalea (exotic flower ) , the fresher welcome programme fornewcomers of GNIPST in the session 2013-14 was held on 8thAugust in GNIPST Auditorium.
One day seminar cum teachers development programme forschool teachers on the theme ofRecent Trends of Life Sciences
in Higher Education organized by GNIPST held on 29th June,
11
-
7/27/2019 gnipst bulletin 29.4.pdf
13/15
25-10-2013
Click here to go at the top
2013 at GNIPST auditorium. The programme was inaugurated by
Prof . Asit Guha, Director of JIS Group, Mr. U.S. Mukherjee, Dy
Director of JIS Group and Dr. Abhijit Sengupta, Director cum
Principal of GNIPST with lamp lighting. The programme started
with an opening song performed by the B.Pharm students of this
institute. The seminar consists of a series of lectures, video
presentations and poster session. On the pre lunch session 4
lectures were given by Dr. Lopamudra Dutta, Mr. Debabrata
Ghosh Dastidar, Ms. Swati Nandy and Ms. Tamalika Chakraborty
respectively. On their presentation the speakers enlighten the
recent development of Pharmacy, Genetics and Microbiology and
their correlation with Life Sciences. On the post lunch session, Ms.Saini Setua and Ms. Sanchari Bhattacharjee explained the recent
development and career opportunities in Biotechnology and
Hospital Management. The programme was concluded with
valedictory session and certificate distribution.
About 50 Higher secondary school teachers from different
schools of Kolkata and North& South 24 Parganas district of
West Bengal participated in this programme. A good interactivesession between participants and speakers was observed in the
seminar. The seminar was a great success with the effort of
faculties, staffs and students of our Institute. It was a unique
discussion platform for school teachers and professional of the
emerging and newer branches of Life Science.
The following B.Pharm. final year students have qualified,
GPAT-2013. We congratulate them all.
AAAmmmaaannnppprrreeeeeettt KKKaaauuurrr,,, MMMooohhhuuuaaaDDDaaasss,,,
SSSooouuurrraaavvvBBBaaagggccchhhiii,,, UUUddddddiiippptttaaa GGGhhhooossshhhDDDaaassstttiiidddaaarrr,,,
12
-
7/27/2019 gnipst bulletin 29.4.pdf
14/15
25-10-2013
Click here to go at the top
SSSiiiddddddaaarrrttthhh SSShhhaaahhh,,, PPPrrraaappptttiiiCCChhhaaakkkrrraaabbbooorrrtttyyy,,,
SSSuuubbbhhhrrraaadddiiipppRRRoooyyyccchhhooouuudddhhhuuurrryyy,,, SSSooouuummmyyyaaajjjiiittt DDDaaasss,,,
MMMooouuunnnooommmuuukkkhhhaaarrrBBBhhhaaattttttaaaccchhhaaarrrjjjeeeeee...
GGGNNNIIIPPPSSSTTT iiisss nnnooowww aaapppppprrrooovvveeeddd bbbyyy AAAIIICCCTTTEEE aaannnddd aaaffffffiiillliiiaaattteeeddd tttooo
WWWBBBUUUTTT fffooorrr cccooonnnddduuuccctttiiinnnggg ttthhheee tttwwwooo yyyeeeaaarrrssspppooosssttt gggrrraaaddduuuaaattteee cccooouuurrrssseee
(((MMM...PPPhhhaaarrrmmm))) iiinnnPPPHHHAAARRRMMMAAACCCEEEUUUTTTIIICCCSSS...TTThhheee aaapppppprrrooovvveeeddd nnnuuummmbbbeeerrr
ooofffssseeeaaatttiiisss 111888...
The general body meeting of APTI, Bengal Branch has been conducted
at GNIPST on 15th June, 2012. The program started with a nice
presentation by Dr. Pulok Kr. Mukherjee, School of Natural Products,
JU on the skill to write a good manuscript for publication in impact
journals. It was followed by nearly two hour long discussion among
more than thirty participants on different aspects of pharmacy
education. Five nonmember participants applied for membership onthat very day.
GNIPST is now approved by AICTE and affiliated to WBUT for
conducting the two years post graduate course (M.Pharm) in
P H A R M A C O L O G Y . The approved number of seat is 18.The number of seats in B.Pharm. has been increased from 60 to 120.
AICTE has sanctioned a release of grant under Research Promotion
Scheme (RPS) during the financial year 2012-13to GNIPST as per the
details below:
a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical
Science & Technology.
13
-
7/27/2019 gnipst bulletin 29.4.pdf
15/15
25-10-2013
Click here to go at the top
b.Principal Investigator: Dr. LopamudraDutta.
c. Grant-in-aid sanctioned:Rs. 16,25000/- only
d.Approved duration: 3 years
e. Title of the project: Screening and identification of potentialmedicinal plant ofPurulia & Bankura districts of West Bengal with
respect to diseases such as diabetes, rheumatism, Jaundice,
hypertension and developing biotechnological tools for enhancing
bioactive molecules in these plants.
14